Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Structure–Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation
Eric W. Bow, John M. Rimoldi
Perspectives in Medicinal Chemistry (2016) Vol. 8
Open Access | Times Cited: 134

Showing 1-25 of 134 citing articles:

Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex
Kaavya Krishna Kumar, Moran Shalev-Benami, Michael J. Robertson, et al.
Cell (2019) Vol. 176, Iss. 3, pp. 448-458.e12
Open Access | Times Cited: 398
A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol
Cinzia Citti, Pasquale Linciano, Fabiana Russo, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 173
Cannabinoids and Cannabinoid Receptors: The Story so Far
Fred Shahbazi, Victoria Grandi, Abhinandan Banerjee, et al.
iScience (2020) Vol. 23, Iss. 7, pp. 101301-101301
Open Access | Times Cited: 159
Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products
Dongchen An, Steve Peigneur, Louise Antonia Hendrickx, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 5064-5064
Open Access | Times Cited: 159
Structural basis of selective cannabinoid CB2 receptor activation
Xiaoting Li, Hao Chang, Jara Bouma, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 46
Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors
Eva Martínez‐Pinilla, Katia Varani, Irene Reyes‐Resina, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 167
Synthetic Pot: Not Your Grandfather’s Marijuana
Benjamin M. Ford, Sherrica Tai, William E. Fantegrossi, et al.
Trends in Pharmacological Sciences (2017) Vol. 38, Iss. 3, pp. 257-276
Open Access | Times Cited: 92
Antidepressant-Like Effect of Terpineol in an Inflammatory Model of Depression: Involvement of the Cannabinoid System and D2 Dopamine Receptor
Graziela Vieira, Juliana Cavalli, Elaine Cristina Dalazen Gonçalves, et al.
Biomolecules (2020) Vol. 10, Iss. 5, pp. 792-792
Open Access | Times Cited: 71
Cannabis and Cannabis Edibles: A Review
Han Peng, Fereidoon Shahidi
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 6, pp. 1751-1774
Closed Access | Times Cited: 63
Clinical management of cannabis withdrawal
Jason P. Connor, Daniel Stjepanović, Alan J. Budney, et al.
Addiction (2021) Vol. 117, Iss. 7, pp. 2075-2095
Open Access | Times Cited: 63
Synthesis and pharmacological activity of the epimers of hexahydrocannabinol (HHC)
Fabiana Russo, Maria Angela Vandelli, Giuseppe Biagini, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 26
Investigation of the intrinsic cannabinoid activity of hemp-derived and semisynthetic cannabinoids with β-arrestin2 recruitment assays—and how this matters for the harm potential of seized drugs
Liesl K. Janssens, Katleen Van Uytfanghe, Jeffrey B. Williams, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 8, pp. 2619-2630
Closed Access | Times Cited: 12
Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse Agonists
Miroslav Kosar, Roman C. Sarott, David A. Sykes, et al.
ACS Central Science (2024) Vol. 10, Iss. 5, pp. 956-968
Open Access | Times Cited: 8
Cannabinoid receptor 1 ligands: Biased signaling mechanisms driving functionally selective drug discovery
Lei Tian, Taotao Qiang, Shanglong Liu, et al.
Pharmacology & Therapeutics (2025), pp. 108795-108795
Closed Access | Times Cited: 1
Phytocanabinoids and synthetic cannabinoids: from recreational consumption to potential therapeutic use – a review
Helena M. Teixeira
Frontiers in Toxicology (2025) Vol. 6
Open Access | Times Cited: 1
Dark Classics in Chemical Neuroscience: Δ9-Tetrahydrocannabinol
Samuel D. Banister, Jonathon C. Arnold, Mark Connor, et al.
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 5, pp. 2160-2175
Closed Access | Times Cited: 69
Rare genetic variants in the endocannabinoid system genes CNR1 and DAGLA are associated with neurological phenotypes in humans
Douglas R. Smith, Christine M. Stanley, Theodore Foss, et al.
PLoS ONE (2017) Vol. 12, Iss. 11, pp. e0187926-e0187926
Open Access | Times Cited: 66
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: Δ9-Tetrahydrocannabutol, the Butyl Homologue of Δ9-Tetrahydrocannabinol
Pasquale Linciano, Cinzia Citti, Livio Luongo, et al.
Journal of Natural Products (2019) Vol. 83, Iss. 1, pp. 88-98
Closed Access | Times Cited: 64
Assessment of Biased Agonism among Distinct Synthetic Cannabinoid Receptor Agonist Scaffolds
Elise Wouters, Jolien Walraed, Michael J. Robertson, et al.
ACS Pharmacology & Translational Science (2019) Vol. 3, Iss. 2, pp. 285-295
Open Access | Times Cited: 56
Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors?
Leontina Elena Filipiuc, Daniela Carmen Ababei, Teodora Alexa‐Stratulat, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1823-1823
Open Access | Times Cited: 53
Biosynthesis and synthetic biology of psychoactive natural products
Cooper S. Jamieson, Joshua Misa, Yi Tang, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 12, pp. 6950-7008
Open Access | Times Cited: 51
Cannabis hyperemesis syndrome: an update on the pathophysiology and management
Abhilash Perisetti
Annals of Gastroenterology (2020)
Open Access | Times Cited: 50
Phytocannabinoid Pharmacology: Medicinal Properties of Cannabis sativa Constituents Aside from the “Big Two”
Peter B. Sampson
Journal of Natural Products (2020) Vol. 84, Iss. 1, pp. 142-160
Closed Access | Times Cited: 50
Mechanistic origin of partial agonism of tetrahydrocannabinol for cannabinoid receptors
Soumajit Dutta, Balaji Selvam, Aditi Das, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 4, pp. 101764-101764
Open Access | Times Cited: 35
Skin applications of cannabidiol: sources, effects, delivery systems, marketed formulations and safety
Beatriz Pires Ferreira, Gustavo Costa, Filipa Mascarenhas‐Melo, et al.
Phytochemistry Reviews (2023) Vol. 22, Iss. 3, pp. 781-828
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top